-
ABOUT USHebei Guangxiang Pharmaceutical Co., Ltd. is specializing in the production of bulk pharmaceuticals, fine pharmaceuticals, intermediate compounds and biopharmaceutical preparations.
-
News CenterAt the forefront of corporate development, we champion the positive energy of the Four Pharmaceutical Companies: fulfilling our duties conscientiously, stepping up to the plate and taking proactive action, embracing new missions, and conducting effective new publicity. In doing so, we aim to enhance the overall competence of our employees, stimulate their enthusiasm, initiative, and creativity, and provide robust ideological guidance and powerful spiritual strength to drive the enterprise forward.
-
INNOVATIONDevelops fine, series, high-end bulk pharmaceutical intermediates and innovative bulk pharmaceutical intermediates with high added value to build variety competition advantages.
-
-
RECRUITGuangxiang has jointly established engineering laboratories, technology research centers and other high-level innovation platforms with CAS, Zhejiang University, Tianjin University and other universities.
-
CONTACTWith stable production, high-quality and reliable service, the company's products have been sold to more than 80 countries such as the United States, the United Kingdom, Germany and the Netherlands
Media Spotlight – Hebei Economic Daily | Pressing the “Fast-Forward” Button on Internationalization: Guangxiang Pharmaceutical Obtains Customs AEO Advanced Certification
Category:
TIME：2025-12-16
AEO, short for Authorized Economic Operator, is a certification scheme promoted by the World Customs Organization. In China, AEO certification represents the highest level of enterprise credit management awarded by Chinese customs. Companies holding this certification enjoy numerous facilitations in international trade, including reduced inspection frequency, lower inspection rates, and shorter customs clearance times. As one of the leading domestic enterprises in the R&D, production, and export of chemical APIs, Guangxiang Pharmaceutical has, in recent years, focused on adapting to changes in both domestic and international markets by continuously pursuing advancements in quality improvement and green manufacturing. Leveraging new technologies such as continuous-flow microreactors and continuous crystallization, the company has successfully addressed multiple common and critical challenges in the production of its flagship products, including caffeine and metronidazole, thereby significantly enhancing product yields and quality metrics. Its product quality has reached industry-leading levels and has earned recognition in international markets.
“In the caffeine raw-materials sector, we have become one of the leading suppliers in the global premium market,” said Zhu Shujie, Chairman of Guangxiang Pharmaceutical. The company’s key products—including caffeine, theophylline, aminophylline, metronidazole, and nifedipine—have each obtained national GMP certification as well as international certifications such as CEP, BRC, FSSC 22000, KOSHER, and HALAL. These products are now exported to more than 60 countries and regions worldwide, with the company’s international competitiveness steadily increasing.
“As overseas markets continue to expand, customers are placing increasingly higher demands on customs clearance efficiency and logistics timeliness, making the need for companies to obtain AEO certification ever more urgent,” said Zhu Shujie. He added that AEO certification involves numerous assessment items and stringent standards, resulting in a relatively low approval rate; however, during the certification process, the company received comprehensive guidance and support from Shijiazhuang Customs and ultimately succeeded in obtaining certification.
“With AEO certification, we will benefit from streamlined customs procedures such as advance declaration and priority processing, which will significantly reduce the time required for export clearance and is expected to cut logistics costs by nearly 10%. This will provide substantial support for us in gaining a competitive edge in the market and enhancing the competitiveness of our products,” said Zhu Shujie. He added that Guangxiang Pharmaceutical will next leverage the prestigious AEO certification to shift its foreign trade operations from “volume-based exports” to “value-driven exports,” thereby making new contributions to the development of Hebei’s pharmaceutical industry.
(Reprinted from the December 16 issue of Hebei Economic Daily)
Keywords:
Recommended News
Share to
SERVICE HOTLINE
E-mail: hbgxzy@hebgxzy.com
Address: The west of Jingliu Road, lingang economic nad technological development zone, cangzhou city, Hebei province
Website
Official WeChat
e-Home
